Voxelwise single‐subject analysis of imaging metabolic response to therapy in neuro‐oncology
Abstract
F‐18‐Fluorodeoxyglucose positron emission tomography (FDG‐PET) has been used to evaluate the metabolic response of metastatic brain tumours to treatment by comparing their tumour glucose metabolism before and after treatment. The standard analysis based on regions‐of‐interest has the advantage of simplicity. However, it is by definition restricted to those regions and is subject to observer variability. In addition, the observed changes in tumour metabolism are often confounded by normal changes in the tissue background, which can be heterogenous. We propose an analysis pipeline for automatically detecting the change at each voxel in the entire brain of a single subject, while adjusting for changes in the background. The complete analysis includes image registration, segmentation, a hierarchical model for background adjustment and voxelwise statistical comparisons. We demonstrate the method's ability to identify areas of tumour response and/or progression in two subjects enrolled in a clinical trial using FDG‐PET to evaluate lapatinib for the treatment of brain metastases in breast cancer patients. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- Dana Foundation
- National Institutes of Health (EB013795)
This publication has 20 references indexed in Scilit:
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast CancerJournal of Clinical Oncology, 2008
- The Lessons of GIST—PET and PET/CT: A New Paradigm for ImagingThe Oncologist, 2008
- CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal TumorAmerican Journal of Roentgenology, 2007
- Unified segmentationNeuroImage, 2005
- Large-Scale Simultaneous Hypothesis TestingJournal of the American Statistical Association, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery RateNeuroImage, 2002
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- On the Origin of Cancer CellsScience, 1956